2026年4月23日 美国东部时间8:34 / 福克斯新闻
司法部长托德·布兰奇的命令将大麻从附表一重新归类为附表三
作者：安德斯·哈格斯特伦，福克斯新闻
代理司法部长托德·布兰奇周四宣布，唐纳德·特朗普总统政府将州许可大麻重新归类为“危险性更低”的药品。
布兰奇签署命令，将经美国食品药品监督管理局（FDA）批准且获州许可的大麻从附表一——该类别专用于海洛因等毒品——调整至监管更宽松的附表三。
“美国司法部正在兑现特朗普总统扩大美国人获得治疗选择的承诺，”布兰奇在一份声明中表示。
“此次重新分类行动允许对该物质的安全性和有效性开展研究，最终将为患者提供更好的护理，为医生提供更可靠的信息，”他说道。
迈克·泰森敦促特朗普兑现大麻改革承诺，批拜登“失败”承诺
司法部长托德·布兰奇。（司法部办公室）
布兰奇指出，该命令目前尚未普遍适用于大麻，但表示该命令启动了“一场设有明确截止日期的新快速听证会，以全面完成大麻的重新分类”。
布兰奇的命令出台仅数天前，唐纳德·特朗普总统于周六签署了另一项行政命令，加快对部分致幻药物作为潜在治疗手段的审查。
“我今天签署的这项行政命令，确实是一个历史性时刻，”特朗普说道。“这些疗法目前已进入临床试验的高级阶段，以确保它们对美国患者既安全又有效。”
退伍军人跨境接受违禁致幻疗法，该疗法正改变战后创伤患者人生
2026年4月18日，华盛顿特区，白宫椭圆形办公室内，唐纳德·特朗普总统展示一项授予伊博格碱药物许可的行政命令。（朱莉娅·德马雷·尼基森/美联社）
总统表示，该行政命令将实施“历史性改革，大幅加快基于致幻药物的新型医学研究和治疗手段的获批进程”。
“在许多案例中，这些试验性疗法对患有严重精神疾病和抑郁症的人群展现出改变人生的潜力，包括我们敬爱的退伍军人，”特朗普在提及退伍军人自杀率时说道。
研究显示：痴呆症风险或与你的心态和人生态度相关
“好消息是，我们其实很早就开始推进这项工作了，相关研究已经开展了相当长一段时间。但你也知道，这类研究通常无论结果如何，最终都不了了之，但我们正在改变这一现状。这项命令将扫除不必要的官僚障碍，改善FDA与退伍军人事务部之间的数据共享，并推动任何获得FDA批准的致幻药物快速完成重新分类，”特朗普继续说道。
唐纳德·特朗普总统在华盛顿特区白宫南草坪向媒体发表讲话。（安娜·穆尼梅/盖蒂图片社）
总统表示：“2024年，斯坦福大学的一项研究中，30名患有创伤性脑损伤的特种部队退伍军人接受了——也就是伊博格碱治疗，记住这个名字，”他还指出，这些患者“在一个月内抑郁和焦虑症状减轻了80%至90%”。
一篇发表在《慢性应激》期刊上的论文称，伊博格碱是一种“从非洲行道树雨林灌木中提取的精神活性吲哚生物碱，几个世纪以来在中非地区用于入会仪式”。
点击此处获取福克斯新闻应用程序
“据报道，伊博格碱治疗可缓解一系列情绪和焦虑症状，并与物质使用障碍患者自我报告的认知功能改善相关。在治疗过程中，伊博格碱能够唤起并重新处理创伤记忆，并带来具有治疗意义的精神和自传内容幻象，这对解决创伤后应激障碍相关的心理问题至关重要，”文章补充道。
本文由美联社协助报道。
安德斯·哈格斯特伦是福克斯新闻数字频道记者，报道全国政治及重大突发新闻事件。可通过Anders.Hagstrom@Fox.com发送爆料线索，或在X平台@Hagstrom_Anders联系他。
Trump admin loosens regulations on state-licensed medical marijuana
April 23, 2026 8:34am EDT / Fox News
AG Todd Blanche’s order reclassifies marijuana from Schedule I to Schedule III
By Anders Hagstrom, Fox News
President Donald Trump’s administration is reclassifying state-licensed marijuana as a “less-dangerous” drug, Acting Attorney General Todd Blanche announced Thursday.
Blanche signed an order reclassifying FDA-approved and state-licensed marijuana from Schedule I – reserved for drugs like heroin – to the less strict Schedule III.
“The Department of Justice is delivering on President Trump’s promise to expand Americans’ access to medical treatment options,” Blanche said in a statement.
“This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information,” he said.
MIKE TYSON URGES TRUMP TO DELIVER ON CANNABIS REFORM AFTER BIDEN’S ‘FAILED’ PLEDGE
Attorney General Todd Blanche.(AG’s Office)
Blanche noted that the order does not yet apply to marijuana generally, but said the order initiates “a new, expedited hearing with set deadlines, to fully reschedule marijuana.”
Blanche’s order comes just days after President Donald Trump signed another executive order Saturday expediting the review of some psychedelic drugs as potential therapy treatments.
“The executive order I’m signing, we’re actually signing the executive order today, is really a moment,” Trump said. “These treatments are currently in the advanced stages of clinical trials to ensure that they’re both safe and effective for the American patients.”
VETERANS CROSS BORDER FOR FORBIDDEN PSYCHEDELIC TREATMENT THAT’S CHANGING LIVES AFTER COMBAT
President Donald Trump holds up an executive order giving Ibogaine drug clearance in the Oval Office of the White House, on Saturday, April 18, 2026, in Washington, D.C.(Julia Demaree Nikhinson/AP)
The president said the executive order would implement “historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs.”
“In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans,” Trump said, citing the veteran suicide rate.
DEMENTIA RISK COULD BE TIED TO YOUR MINDSET AND OUTLOOK ON LIFE, STUDY SUGGESTS
“And the nice part is we’re actually doing this early, but it has been going on. Research has been going on for quite some time. But, you know, usually with things like this, nothing ever happens, no matter how the research ends up, but we’re changing that. This order will clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA and the Department of Veterans Affairs, and facilitate fast rescheduling of any psychedelic drugs that become FDA approved,” Trump continued.
President Donald Trump speaks to the media on the South Lawn of the White House in Washington, D.C.(Anna Moneymaker/Getty Images)
The president said, “in 2024, a study from Stanford University, 30 special operation veterans with traumatic brain injuries underwent — it’s called ibogaine treatment, remember the name,” noting that they “experienced an 80 to 90% reduction in symptoms of depression and anxiety within one month.”
A paper published in the journal Chronic Stress said ibogaine is a “psychoactive indole alkaloid which is extracted from the Tabernanthe iboga rainforest shrub and has been used for centuries in Central Africa for initiatory rituals.”
CLICK HERE TO GET THE FOX NEWS APP
“Ibogaine treatment is reported to alleviate a spectrum of mood and anxiety symptoms and is associated with self-reported improvements in cognitive functioning in individuals with substance-use disorders. During treatment, ibogaine allows the evocation and reprocessing of traumatic memories and occasions therapeutic and meaningful visions of spiritual and autobiographical content, which are of central relevance in addressing PTSD-related psychological content,” it added.
The Associated Press contributed to this report.
Anders Hagstrom is a reporter with Fox News Digital covering national politics and major breaking news events. Send tips to Anders.Hagstrom@Fox.com, or on X: @Hagstrom_Anders.
发表回复